SCOUT: An Exploratory Approach to Scouting Dose-Relevant Covariates.

Area of Science:

• Pharmacometrics
• Drug Development
• Precision Medicine

Background:

• Identifying patient-specific factors (covariates) is crucial for precise drug dosing.
• Traditional methods for covariate analysis are time-consuming and may miss clinically relevant factors.

Purpose of the Study:

• To introduce the Systematic Covariate Observational Uncovering Technique (SCOUT) for efficient covariate exploration.
• To shift focus from parameter-level effects to individual optimal dose for clinical relevance.

Main Methods:

• Developed SCOUT, a novel approach for covariate analysis.
• Validated SCOUT using simulations, amikacin PK data, and eribulin PK/PD modeling.

Main Results:

• SCOUT accurately estimated individual optimal doses with minimal bias.
• Successfully identified known covariates for amikacin (weight, renal function) and eribulin (neutrophil count).
• Provided evidence for optimizing dosing intervals.

Conclusions:

• SCOUT is an efficient hypothesis-generating tool for pharmacometricians.
• Facilitates prioritization of clinically impactful covariates and narrows model-building search spaces.
• Supports rational and efficient clinical decision-making in precision medicine.